Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20130812014333N108Phase 2Completed
Phase 2, single-blind trial of dexmedetomidine (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Bleeding, Nausea and 2 more. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20130812014333N108.